Related Experiment Video
Updated: Feb 14, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
Published on: April 25, 2025
Hypoxia Activates Src and Promotes Endocytosis Which Decreases MMP-2 Activity and Aggravates Renal Interstitial
Zhengyuan Cheng1, Lei Liu2, Zhi Wang3
1Department of pathology and pathophysiology, Medical School, Southeast University, Dingjiaqiao 87, Gulou district, Nanjing 210009, China. 230159257@seu.edu.cn.
Abstract:
The aggravation of renal interstitial fibrosis in the advanced-stage of chronic kidney disease is related to decreased matrix metalloproteinase-2 (MMP-2) activity, which is induced by hypoxia in the kidney; however, the specific mechanism remains unclear. We previously demonstrated that inhibition of Caveolin-1, a key gene involved in endocytosis, increased MMP-2 activity in hypoxic HK-2 cells. It has been reported that activated Src (phospho-Src Tyr416) is a key molecule in multiple fibrotic pathways. However, whether Src functions on the regulation of Caveolin-1 and MMP-2 activity in hypoxic HK-2 cells remains poorly understood. To explore the underlying mechanism, a rat model of renal interstitial fibrosis was established, then we observed obvious hypoxia in fibrotic kidney tissue and the protein levels of phospho-Src and Caveolin-1 increased, while MMP-2 activity decreased. Next, we treated HK-2 cells with the phospho-Src inhibitor PP1. Compared with normal cells grown in hypoxia, in cells treated with PP1, the protein levels of phospho-Src and Caveolin-1 decreased, as did the protein levels of the MMP-2-activity-regulated molecules RECK (reversion-inducing-cysteine-rich protein with kazal motifs) and TIMP-2 (tissue inhibitor of metalloproteinase-2), while the protein level of MT1-MMP (membrane type 1-matrix metalloproteinase) increased and MMP-2 activity was enhanced. Therefore, hypoxia promotes the phosphorylation of Src and phospho-Src can enhance the endocytosis of HK-2 cells, which leads to decreased MMP-2 activity and aggravates renal interstitial fibrosis.
Insights
Hypoxia in chronic kidney disease decreases matrix metalloproteinase-2 (MMP-2) activity by increasing phospho-Src and Caveolin-1. Inhibiting phospho-Src restores MMP-2 activity, potentially treating renal fibrosis.
Area of Science:
- Nephrology
- Cell Biology
- Molecular Biology
Background:
- Renal interstitial fibrosis in chronic kidney disease is linked to reduced matrix metalloproteinase-2 (MMP-2) activity.
- Hypoxia-induced mechanisms regulating MMP-2 activity and fibrosis remain unclear.
- Caveolin-1 and activated Src (phospho-Src) are implicated in fibrotic pathways.
Purpose of the Study:
- To elucidate the mechanism by which hypoxia affects MMP-2 activity in renal interstitial fibrosis.
- To investigate the role of Src and Caveolin-1 in regulating MMP-2 activity under hypoxic conditions.
- To explore potential therapeutic targets for renal fibrosis.
Main Methods:
- Established a rat model of renal interstitial fibrosis.
- Analyzed protein levels of phospho-Src, Caveolin-1, RECK, TIMP-2, and MT1-MMP in kidney tissue and HK-2 cells.
- Assessed MMP-2 activity in HK-2 cells treated with a phospho-Src inhibitor (PP1) under hypoxia.
Main Results:
- Hypoxic fibrotic kidney tissue showed increased phospho-Src and Caveolin-1, with decreased MMP-2 activity.
- PP1 treatment in hypoxic HK-2 cells reduced phospho-Src and Caveolin-1 levels.
- PP1 treatment enhanced MMP-2 activity and altered levels of MMP-2 regulators (RECK, TIMP-2, MT1-MMP).
Conclusions:
- Hypoxia promotes Src phosphorylation, which enhances Caveolin-1-mediated endocytosis in HK-2 cells.
- This process leads to decreased MMP-2 activity, aggravating renal interstitial fibrosis.
- Targeting phospho-Src may offer a therapeutic strategy for renal fibrosis.
More Related Videos
Related Concept Videos
Co-activators and Co-repressors
Receptor-mediated Endocytosis
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
tRNA Activation
Activation Energy

